Press Enter / Return to begin your search.

1995: The Year Everything Changed

Why everything from Amazon and eBay to Windows 95 and the PalmPilot came along in one memorable, wildly innovative 12-month period.

On November 6, 1995, the first issue of Fast Company debuted. Its founders, Alan Webber and Bill Taylor, were former Harvard Business Review editors who had been working on the idea for a while: in fact, they’d produced a prototype version in 1993. With funding from media tycoon Mortimer Zuckerman, they began regular publication with a cover that famously declared that business is personal, computing is social, and knowledge is power. The mantra was so prescient that it still captures our perspective two decades later.

Read Full Story

Read More

Are You Overscheduling?

It’s time to take control of your calendar.

Feeling overwhelmed? It’s time to take control of your calendar. Find out what you should consider before you say “yes” to an opportunity, when you should squeeze something into your schedule, and what kind of calendar you should be using. Do you use any of these tips? Tell us at #WorkSmart.

Read Full Story

Read More

Yikes—Does My Startup Need To Become A Tech Company, After All?

Mark Bittman has always thought of Purple Carrot as a food startup—but now he wonders if he needs to think of it as technology company, too.

From late spring to early summer, during the first days of my involvement with meal kit startup Purple Carrot, we fielded many questions about our “tech side.” These came primarily from a few influential Silicon Valley VCs who would directly ask questions like, “How are you using technology to make your startup more defensible?”

Read Full Story

Read More

KaloBios Files for Bankruptcy After Former CEO Martin Shkreli’s Arrest

KaloBios Pharmaceuticals had previously taken strategic investment from Shkreli.

The bad news keeps on coming for business associates of Martin Shrekli, the “bad boy” of pharmaceuticals who made a name for himself earlier this year when he hiked up the price of an AIDS drug from $13.50 to $750. Less than two weeks after it fired Shkreli as CEO, South San Francisco-based cancer drug research company KaloBios Pharmaceuticals Inc. filed for bankruptcy.

Read Full Story

Read More